Finished
Potential Advantages of Robotic Total Gastrectomy in Advanced Middle-Upper Gastric Cancer: A Multicenter Propensity Score Matching Analysis
NCT06941168 · Fujian Medical University · Updated 23 April 2025
- What is being tested
- Robotic Total Gastrectomy and Laparoscopic Total Gastrectomy
- For
- Advanced Gastric Cancer
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 20 years to 85 years. About 1,099 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started Jan 2015, ends Aug 2024. Registered 23 April 2025.
- Results
- None posted yet.
In the researchers' words
This multicenter retrospective cohort study aimed to evaluate the potential advantages of robotic total gastrectomy (RTG) compared to laparoscopic total gastrectomy (LTG) in patients with advanced middle and upper gastric cancer (AMUGC). A total of 1,099 patients who underwent radical total gastrectomy between 2013 and 2020 were included. After strict inclusion and exclusion criteria, propensity score matching (1:1) was conducted to balance baseline characteristics. The primary endpoint was 3-year disease-free survival (DFS), with secondary outcomes including overall survival, recurrence rates and patterns, and perioperative outcomes. All procedures were performed by experienced surgeons following standardized protocols across eight high-volume centers. Data quality was ensured through a centralized electronic system, unified training, and rigorous verification. This study provides real-world evidence on surgical outcomes and long-term prognosis, contributing to clinical decision-making in the treatment of AMUGC.
Sites
- Department of Gastric Surgery, Fujian Medical University Union HospitalFuzhou, Fujian, China
